|
Volumn 83, Issue 11, 2008, Pages 1296-1297
|
Fluvastatin, rhabdomyolysis, and myotoxicity
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ATORVASTATIN;
CERIVASTATIN;
FLUINDOSTATIN;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
PRAVASTATIN;
SIMVASTATIN;
APOPTOSIS;
DRUG SAFETY;
DRUG SUBSTITUTION;
HUMAN;
INCIDENCE;
LETTER;
MAJOR CLINICAL STUDY;
MITOCHONDRIAL MEMBRANE POTENTIAL;
MITOCHONDRIAL TOXICITY;
MUSCLE MITOCHONDRION;
MUSCLE TOXICITY;
MYALGIA;
MYOBLAST;
MYOPATHY;
NEUROTOXICITY;
PATIENT MONITORING;
PRESCRIPTION;
RHABDOMYOLYSIS;
RISK BENEFIT ANALYSIS;
TOXICITY;
|
EID: 55549111906
PISSN: 00256196
EISSN: None
Source Type: Journal
DOI: 10.4065/83.11.1296 Document Type: Letter |
Times cited : (2)
|
References (5)
|